Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.
UBS analyst Ashwani Verma said the launch of Selarsdi "can establish the success path and playbook for more biosimilars to come." Teva and Alvotech's Selarsdi, like Stelara, is approved for the ...
REYKJAVIK, Iceland and PARSIPPANY, NJ, USA I1, 2025 I Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback